Skip to main content

caspofungine

J - Antiinfectives For Systemic Use -> J02 - Antimycotics For Systemic Use -> J02A - Antimycotics For Systemic Use -> J02AX - Other Antimycotics For Systemic Use -> J02AX04 - Caspofungin
Administration category: Free Medicine group: antifungal Brand name: Cancidas

Standard dosages

≥ 18 years
Weight ROA Load Dosage
< 80 kg
ROA:
iv
Load:
70mg
Dosage:
50mg 1 dd
≥ 80 kg
ROA:
iv
Load:
70mg
Dosage:
70mg 1 dd

Kidney function

Renal elimination: 2%
Dosage: independent on kidney function

Interactions

Interaction with (ATC): Expected effect:
Interaction with (ATC):
L04AD01 - Ciclosporin
Expected effect:
verhoging plasmaconcentratie caspofungin
Interaction with (ATC):
L04AD02 - Tacrolimus
Expected effect:
verlaging dalconcentratie tacrolimus
Interaction with (ATC):
J04AB02 - Rifampicin
Expected effect:
verlaging plasmaconcentratie caspofungin
Interaction with (ATC):
N03AB02 - Phenytoin
Expected effect:
verlaging plasmaconcentratie caspofungin
Interaction with (ATC):
N03AF01 - Carbamazepine
Expected effect:
verlaging plasmaconcentratie caspofungin
Interaction with (ATC):
H02AB02 - Dexamethasone
Expected effect:
verlaging plasmaconcentratie caspofungin
Interaction with (ATC):
J05AG01 - Nevirapine
Expected effect:
verlaging plasmaconcentratie caspofungin

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.
Metadata

Swab vid: M-2091.1
Updated: 06/16/2019 - 20:05
Status: Published

External links
Menu position